Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: An analysis from the CADILLAC trial

American Heart Journal

Volumn 147, Issue 4, 2004, Pages 669-675

  Prasad, Abhiram ^a   Stone, Gregg W ^b   Aymong, Eve ^b   Zimetbaum, Peter J ^c   McLaughlin, Michael ^c   Mehran, Roxana ^b   Garcia, Eulogio ^d   Tcheng, James E ^e   Cox, David A ^f   Grines, Cindy L ^g   Gersh, Bernard J ^a  

^a MAYO CLINIC   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f Mid Carolina Cardiology   (United States)

^g WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEVICE; DIAGNOSTIC PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REPERFUSION; ST SEGMENT; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STENTS;

EID: 3142544686     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.11.010     Document Type: Article

References (23)

1. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 2:1988;349-360
2. Gusto III Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 337:1997;1118-1123
3. Maggioni A.P., Maseri A., Franzoni M.G., et al. Age-related increase mortality among patients with first myocardial infarctions treated with thrombolysis The investigators of the Gruppo Italiano per lo studio della Sopravvivenza nell'Infarcto Miocardio (GISSI-2). N Engl J Med. 329:1993;1442-1449
4. Grines C.L., Browne K.F., Marco J., et al. GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 336:1997;1621-1628
5. Stone G.W., Grines C.L., Browne K.F., et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era The Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol. 25:1995;370-377
6. Holmes D.R., White H.D., Pieper K.S., et al. Effect of age on outcome with primary angioplasty versus thrombolytics. J Am Coll Cardiol. 33:1999;412-419
7. Anonymous. From the Centers for Disease Control. National Mortality Followback Survey: characteristics of persons who died from diseases of the heart-United States, 1986. JAMA 1989;262:1587-91
8. Krumholz H.M., Chen J., Chen Y.T., et al. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction Results from the Cooperative Cardiovascular Project. J Am Coll Cardiol. 38:2001;453-459
9. Mehta R.H., Rathore S.S., Radford M.J., et al. Acute myocardial infarction in the elderly Differences by age. J Am Coll Cardiol. 38:2001;736-741
10. Abetes P., Ferrara N., Cacciatore F., et al. Angina-induced protection against myocardial infarction in adult and elderly patients A loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol. 30:1997;947-954
11. Lee T.M., Su S.F., Chou T.F., et al. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation. 105:2002;334-340
12. GISSI-Avoidable Delay Study Group. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy A GISSI-generated study. Arch Intern Med. 155:1995;1481-1488
13. Schroder R., Dissmann R., Bruggemann T., et al. Extent of early ST-segment elevation resolution A simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol. 24:1994;384-391
14. Schroder R., Wegscheider K., Schroder K., et al. Extent of early ST segment elevation resolution A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol. 26:1995;1657-1664
15. Santoro G.M., Antoniucci D., Valenti R., et al. Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction. Am J Cardiol. 80:1997;685-689
16. Gibson C.M., Cannon C.P., Murphy S.A., et al. The relationship of the TIMI myocardial perfusion grade to mortality after thrombolytic administration. Circulation. 101:2000;125-130
17. de Lemos J.A., Antman E.M., McCabe C.H., et al. ST-segment resolution and infarct related artery patency and flow after thrombolytic therapy. Am J Cardiol. 85:2000;299-304
18. Stone G.W., Grines C.L., Cox D.A., et al. The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 346:2002;957-966
19. Miller T.D., Christian T.F., Hodge D.O., et al. Comparison of acute myocardial infarct size to two-year mortality in patients <65 to those > or = 65 years of age. Am J Cardiol. 84:1999;1170-1175
20. Miller T.D., Piegas L.S., Gibbons R.J., et al. Role of infarct size in explaining the higher mortality in older patients with acute myocardial infarction. Am J Cardiol. 90:2002;1370-1374
21. Matetzky S., Novikov M., Gruberg L., et al. The significance persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol. 34:1999;1932-1938
22. Holmes D.R. Jr, Berger P.B., Garratt K.N., et al. Application of the New York State PTCA mortality model in patients undergoing stent implantation. Circulation. 102:2000;517-522
23. Singh M., Lennon R.J., Holmes D.R. Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol. 40:2002;387-393